New EU-Funded Consortium Aims To Develop Targeted Cancer Vaccines
This article was originally published in The Pink Sheet Daily
Executive Summary
A clinical trial is expected to start in the U.S. and Europe in 2014 of an individualized approach to developing a cancer vaccine for glioblastoma patients.